Table 2 Association with early disease progression in early HIV-1 seroconverters
| Â | Univariate results | Multivariate results | ||||
|---|---|---|---|---|---|---|
| Â | HR | 95% CI | p value | HR | 95% CI | p value |
Age (≥40 vs. <40) | 1.21 | 0.73–1.93 | 0.4411 | 1.25 | 0.75–2.00 | 0.3739 |
Calendar year at diagnosis (2007–2010 vs. 2003–2006) | 1.36 | 0.93–2.03 | 0.1170 | 1.26 | 0.83–1.93 | 0.2823 |
With baseline CD4 cell count <400 cells/μL | 4.02 | 2.70–6.08 | <0.0001 | 3.88 | 2.57–5.96 | <0.0001 |
Group | Â | Â | Â | Â | Â | Â |
 Asymptomatic recent group | 1 |  |  | 1 |  |  |
 Symptomatic recent group | 1.62 | 0.97–2.74 | 0.0621 | 1.12 | 0.67–1.93 | 0.6772 |
 Symptomatic acute group | 2.95 | 1.79–4.99 | <0.0001 | 1.93 | 1.14–3.36 | 0.0140 |